Slovenia’s leading listed companies are capitalising on global mega-trends such as an ageing population, energy transition ...

European regulators have finally approved the Alzheimer’s treatment Leqembi after an advisory committee initially rejected the drug last summer.

Belgian insurer Ageas (AGESY) (AGESF) to buy UK-based personal lines insurer from private equity firm Bain Capital in a deal worth £1.295B.